about
Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)Type 1 diabetesAnti-Insulin Immune Responses Are Detectable in Dogs with Spontaneous DiabetesLocalization of nucleic acid-sensing toll-like receptors in human and mouse pancreas.Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants.Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of diseaseHigh glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis.Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes.The prospect of induced pluripotent stem cells for diabetes mellitus treatmentPathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.Stem cells in clinical practice: applications and warnings.Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals.Concurrent detection of secreted products from human lymphocytes by microengraving: cytokines and antigen-reactive antibodiesLow triglyceride levels are associated with a better metabolic control in patients with type 1 diabetes.Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes.Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of β-cell autoimmunityGAD65 autoantibodies and its role as biomarker of Type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA).Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.The pathogenesis and natural history of type 1 diabetes.The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypesImpact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).Update in endocrine autoimmunity.Teaching children with diabetes about adequate dietary choices.The natural history of type 1A diabetes.Transfusion of nonobese diabetic mice with allogeneic newborn blood ameliorates autoimmune diabetes and modifies the expression of selected immune response genes.Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1Common variants on cytotoxic T lymphocyte antigen-4 polymorphisms contributes to type 1 diabetes susceptibility: evidence based on 58 studies.Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus.Emerging treatments for the prevention of type 1 diabetes.Cutaneous Manifestations of Diabetes Mellitus: A Review.Insulin therapy versus cell-based therapy for type 1 diabetes mellitus: what lies ahead?[Heterogeneity of type 1 diabetes mellitus].Breaking ground on translational stem cell research.Evaluation of T cell stimulation by thyrotropin-receptor epitopes in Graves' disease.Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantationStem Cell Applications for Treatment of Cancer and Autoimmune Diseases: Its Promises, Obstacles, and Future Perspectives
P2860
Q24631660-13C97E21-3BE4-4828-BE3F-ADD8CE8DAD2FQ27000491-1A1C5083-9175-4A07-BDD9-F578300B04BCQ27316266-ECA82A9D-5EA4-4CF4-9279-C2B32BC06639Q33364494-AAADED92-E5CD-465A-96D4-CBA175EBA1BEQ33683763-BBFBBDD3-ADEE-463B-917C-5429158C3165Q33729769-FB4FD51A-ABBE-44B4-B4AB-15443A8CC83AQ33890987-065F8625-41FA-44AF-9257-79FB25AE4E2FQ34341897-E04C3335-C290-437C-8428-136AE85FDDACQ34475454-D4930A47-2ADE-433C-92CB-90F3F396DBC8Q34503601-03180126-22AD-400B-A9FB-241EB677EF1FQ34552765-42109FEC-3D75-4383-9326-A8A3C134296FQ34586781-358FAD56-F0D6-43A7-A585-36BFA1B662D1Q34803611-54FBD7C9-3FE8-4194-AD84-96025420674EQ35232700-7641F714-81C2-4BCE-81BA-5A908C51C5A9Q35405076-10E1BB2C-8140-4A90-A8D5-1171D8A2D791Q35857726-DD2ABBDD-A8FF-41A2-B142-14D31DD2825EQ36137876-456BDD71-4D24-4452-8AD4-76D1D1EC6D3DQ36330292-13A5FF49-3D63-484A-ACC6-3442BAD4A2AEQ36526611-96C5ED6E-9B4A-40AD-B4F1-7CA31466719CQ36807498-7064F969-3305-4696-9AE0-7A32D30E4A33Q36842573-B6231273-D0D1-483A-99B4-08BA9E4982E0Q36964828-3F9E1149-337E-40FE-A137-04062C73821AQ37079313-BD706819-B96E-48FD-A3CB-D443D880CAC6Q37148312-344D5D82-42DF-465D-9D70-F09E7289C223Q37188345-B4B9030A-1228-45A8-91C0-5B26C7CA16FEQ37319146-17238DA3-2A2D-44BF-9EE3-6260657F9791Q37509820-E74EDF1D-6201-461B-AB21-E5E035BB86A5Q37680288-C893AE99-17E1-4F86-839D-FE2CFE2C928FQ37729179-7802BB3E-DE03-4B13-952B-BEE89285E0B6Q39218289-2DBC6DC8-F4F6-4378-91D0-1EE112E85FADQ42549612-8C7C9B9B-D6E2-448A-96FE-C034186395C7Q46625451-D5B68643-B2C3-4F64-BEEE-A14D408A94E5Q51142450-9E6F9EC5-39C8-4389-A483-95B989D1A54EQ51741741-94C9F432-C09F-4001-A250-7D785B1E75FBQ56787009-41342F96-980E-4FA6-B1B4-B2B21B6F9CA4Q57826825-BC1AB8C5-D445-4593-99DD-BAE8F8847262
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Update in type 1 diabetes.
@en
type
label
Update in type 1 diabetes.
@en
prefLabel
Update in type 1 diabetes.
@en
P356
P1476
Update in type 1 diabetes.
@en
P2093
George S Eisenbarth
P304
P356
10.1210/JC.2007-0339
P407
P577
2007-07-01T00:00:00Z